The urine microbiome: what's normal and what's pathological? Microbiome-based treatment and prevention of urinary tract infections: A review

Cover Page

Cite item

Full Text

Abstract

Research on the urine microbiome dates back approximately 150 years. Historically, the prevailing view was that the urinary system of a healthy individual is sterile. This paradigm, which seemed unshakable, defined approaches to diagnosing and treating urinary tract infections. Only in the last few decades has the scientific community's opinion on this issue changed radically. Progress in microbiological research has enabled the use of advanced culture and novel molecular genetic methods to identify microorganisms inhabiting the urinary tract. Finally, the well-established dogma of the urine sterility in a healthy person was shattered. Not only bacteria but also viruses and fungi are found in the urine. There is currently no consensus on which composition of the urine microbiota should be considered normal. However, the accumulated data indicate that changes in the urobiome's taxonomic composition can serve as predictors of various pathological processes. The underlying pathogenetic mechanisms remain to be further studied. A correlation has been identified between altered urinary microbiota and the development of both inflammatory and non-inflammatory diseases, in particular, benign prostatic hyperplasia, interstitial cystitis/painful bladder syndrome, urolithiasis, overactive bladder, urinary incontinence, and even bladder cancer. Of particular relevance in pediatric practice is the search for methods to prevent and treat urinary tract infections, thereby preserving and maintaining the diversity of microorganisms colonizing this system. One such method is the use of combined herbal medicinal products, such as Canephron N, which has diverse effects due to its active components. A distinctive feature of this herbal medicinal product, along with its multifaceted therapeutic effect, is its antimicrobial activity without inhibiting the commensal microbiota of the urinary tract. Canephron N is a valuable tool in the pediatrician's arsenal, helping maintain the fragile balance of the urobiome and prevent several pathological conditions.

About the authors

Irina N. Zakharova

Russian Medical Academy of Continuous Professional Education

Author for correspondence.
Email: zakharova-rmapo@yandex.ru
ORCID iD: 0000-0003-4200-4598

D. Sci. (Med.), Prof.

Russian Federation, Moscow

Ismail M. Osmanov

Bashlyaeva Children's City Clinical Hospital; Pirogov Russian National Research Medical University (Pirogov University)

Email: zakharova-rmapo@yandex.ru
ORCID iD: 0000-0003-3181-9601

D. Sci. (Med.), Prof.

Russian Federation, Moscow; Moscow

Gulfizat B. Bekmurzaeva

Russian Medical Academy of Continuous Professional Education; Bashlyaeva Children's City Clinical Hospital

Email: zakharova-rmapo@yandex.ru

Cand. Sci. (Med.)

Russian Federation, Moscow; Moscow

Polina D. Anisimova

Russian Medical Academy of Continuous Professional Education

Email: zakharova-rmapo@yandex.ru
ORCID iD: 0009-0007-4550-1502

Graduate Student

Russian Federation, Moscow

Viktoriya D. Churilova

Russian Medical Academy of Continuous Professional Education

Email: zakharova-rmapo@yandex.ru
ORCID iD: 0009-0009-0335-0704

Assistant

Russian Federation, Moscow

References

  1. Prescott SL. History of medicine: Origin of the term microbiome and why it matters. Human Microbiome Journal. 2017;4:24-5. doi: 10.1016/j.humic.2017.05.004
  2. Sender R, Fuchs S, Milo R. Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans. Cell. 2016;164(3):337-40. doi: 10.1016/j.cell.2016.01.013
  3. Reasoner SA, Francis J, Hadjifrangiskou M. The urinary microbiome: the next frontier of bacterial ecology. J Bacteriol. 2025;207(8):e0010525. doi: 10.1128/jb.00105-25
  4. Kass EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians. 1956;69:56-64.
  5. Maskell RM. The natural history of urinary tract infection in women. Med Hypotheses. 2010;74(5):802-6. doi: 10.1016/j.mehy.2009.12.011
  6. Perez-Carrasco V, Soriano-Lerma A, Soriano M, et al. Urinary Microbiome: Yin and Yang of the Urinary Tract. Front Cell Infect Microbiol. 2021;11:617002. doi: 10.3389/fcimb.2021.617002
  7. Price TK, Dune T, Hilt EE, et al. The Clinical Urine Culture: Enhanced Techniques Improve Detection of Clinically Relevant Microorganisms. J Clin Microbiol. 2016;54(5):1216-22. doi: 10.1128/JCM.00044-16
  8. Слесаревская М.Н., Кузьмин И.В., Жумадиллаев К.Г., и др. Микробиом и микробиота мочи: современные представления и гендерные особенности. Урологические ведомости. 2022;12(2):157-65 [Slesarevskaya MN, Kuzmin IV, Zhumadillayev KG, et al. Microbiome and urine microbiota: modern concepts and gender features. Urology reports (St.-Petersburg). 2022;12(2):157-65 (in Russian)]. doi: 10.17816/uroved109278
  9. Pearce MM, Hilt EE, Rosenfeld AB, et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio. 2014;5(4):e01283-14. doi: 10.1128/mBio.01283-14
  10. Carrigg C, Rice O, Kavanagh S, et al. DNA extraction method affects microbial community profiles from soils and sediment. Appl Microbiol Biotechnol. 2007;77(4): 955-64. doi: 10.1007/s00253-007-1219-y
  11. Felczykowska A, Krajewska A, Zielińska S, Łoś JM. Sampling, metadata and DNA extraction – important steps in metagenomic studies. Acta Biochim Pol. 2015;62(1):151-60. doi: 10.18388/abp.2014_916
  12. Bukin YS, Galachyants YP, Morozov IV, et al. The effect of 16S rRNA region choice on bacterial community metabarcoding results. Sci Data. 2019;6:190007. doi: 10.1038/sdata.2019.7
  13. Kim JK, Song SH, Jung G, et al. Possibilities and limitations of using low biomass samples for urologic disease and microbiome research. Prostate Int. 2022;10(4):169-80. doi: 10.1016/j.prnil.2022.10.001
  14. LaRocco MT, Franek J, Leibach EK, et al. Effectiveness of Preanalytic Practices on Contamination and Diagnostic Accuracy of Urine Cultures: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis. Clin Microbiol Rev. 2016;29(1):105-47. doi: 10.1128/CMR.00030-15
  15. Pohl HG, Groah SL, Pérez-Losada M, et al. The Urine Microbiome of Healthy Men and Women Differs by Urine Collection Method. Int Neurourol J. 2020;24(1):41-51. doi: 10.5213/inj.1938244.122
  16. Du J, Khemmani M, Halverson T, et al. Cataloging the phylogenetic diversity of human bladder bacterial isolates. Genome Biol. 2024;25(1):75. doi: 10.1186/s13059-024-03216-8
  17. Kinneman L, Zhu W, Wong WSW, et al. Assessment of the Urinary Microbiome in Children Younger Than 48 Months. Pediatr Infect Dis J. 2020;39(7):565-70. doi: 10.1097/INF.0000000000002622
  18. Storm DW, Copp HL, Halverson TM, et al. A Child’s urine is not sterile: A pilot study evaluating the Pediatric Urinary Microbiome. J Pediatr Urol. 2022;18(3):383-92. doi: 10.1016/j.jpurol.2022.02.025
  19. Qin J, Shi X, Xu J, et al. Characterization of the Genitourinary Microbiome of 1,165 Middle-Aged and Elderly Healthy Individuals. Front Microbiol. 2021;12:673969. doi: 10.3389/fmicb.2021.673969
  20. Roth RS, Liden M, Huttner A. The urobiome in men and women: a clinical review. Clin Microbiol Infect. 2023;29(10):1242-48. doi: 10.1016/j.cmi.2022.08.010
  21. Pearce MM, Zilliox MJ, Rosenfeld AB, et al. The female urinary microbiome in urgency urinary incontinence. Am J Obstet Gynecol. 2015;213(3):347.e1-11. doi: 10.1016/j.ajog.2015.07.009
  22. Siddiqui NY, Ma L, Brubaker L, et al. Updating Urinary Microbiome Analyses to Enhance Biologic Interpretation. Front Cell Infect Microbiol. 2022;12:789439. doi: 10.3389/fcimb.2022.789439
  23. Ammitzbøll N, Bau BPJ, Bundgaard-Nielsen C, et al. Pre- and postmenopausal women have different core urinary microbiota. Sci Rep. 2021;11(1):2212. doi: 10.1038/s41598-021-81790-8
  24. Nickel JC, Stephens A, Ackerman AL, et al. The healthy urinary microbiome in asymptomatic participants in the MAPP Network Study: Relation to gender, age, and menopausal status. Can Urol Assoc J. 2022;16(9):E448-54. doi: 10.5489/cuaj.7775
  25. Bowie KR, Garzotto M, Orwoll E, Karstens L. Body mass index and benign prostatic hyperplasia correlate with urinary microbiome diversity and lower urinary tract symptoms in men. Commun Med (Lond). 2025;5(1):159. doi: 10.1038/s43856-025-00866-y
  26. Price TK, Lin H, Gao X, et al. Bladder bacterial diversity differs in continent and incontinent women: a cross-sectional study. Am J Obstet Gynecol. 2020;223(5):729.e1-729.e10. doi: 10.1016/j.ajog.2020.04.033
  27. Zárate S, Taboada B, Yocupicio-Monroy M, Arias CF. Human Virome. Arch Med Res. 2017;48(8):701-16. doi: 10.1016/j.arcmed.2018.01.005
  28. Santiago-Rodriguez TM, Ly M, Bonilla N, Pride DT. The human urine virome in association with urinary tract infections. Front Microbiol. 2015;6:14. doi: 10.3389/fmicb.2015.00014
  29. Atkinson AL, Atwood WJ. Fifty Years of JC Polyomavirus: A Brief Overview and Remaining Questions. Viruses. 2020;12(9):969. doi: 10.3390/v12090969
  30. Garretto A, Miller-Ensminger T, Wolfe AJ, Putonti C. Bacteriophages of the lower urinary tract. Nat Rev Urol. 2019;16(7):422-32. doi: 10.1038/s41585-019-0192-4
  31. Hassall A. On the Development of Torulæ in the Urine, and on the relation of these Fungi to Albuminous and Saccharine Urine. Med Chir Trans. 1853;36:23-78.9. doi: 10.1177/095952875303600103
  32. Ghannoum MA, Jurevic RJ, Mukherjee PK, et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010;6(1):e1000713. doi: 10.1371/journal.ppat.1000713
  33. Ackerman AL, Underhill DM. The mycobiome of the human urinary tract: potential roles for fungi in urology. Ann Transl Med. 2017;5(2):31. doi: 10.21037/atm.2016.12.69
  34. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269-84. doi: 10.1038/nrmicro3432
  35. Robino L, Navarro N, Canales-Huerta N, et al. Urogenital microbiome, intracellular bacterial communities, and their contribution to urinary tract infections. Microbiol Spectr. 2025;13(11). doi: 10.1128/spectrum.01247-25
  36. Whiteside SA, Razvi H, Dave S, et al. The microbiome of the urinary tract – a role beyond infection. Nat Rev Urol. 2015;12(2):81-90. doi: 10.1038/nrurol.2014.361
  37. Karlsson M, Scherbak N, Reid G, Jass J. Lactobacillus rhamnosus GR-1 enhances NF-kappaB activation in Escherichia coli-stimulated urinary bladder cells through TLR4. BMC Microbiol. 2012;12:15. doi: 10.1186/1471-2180-12-15
  38. Ohlemacher SI, Giblin DE, d’Avignon DA, et al. Enterobacteria secrete an inhibitor of Pseudomonas virulence during clinical bacteriuria. J Clin Invest. 2017;127(11): 4018-30. doi: 10.1172/JCI92464
  39. Lai HC, Chang SN, Lin HC, et al. Association between urine pH and common uropathogens in children with urinary tract infections. J Microbiol Immunol Infect. 2021;54(2):290-8. doi: 10.1016/j.jmii.2019.08.002
  40. Shrestha LB, Baral R, Poudel P, Khanal B. Clinical, etiological and antimicrobial susceptibility profile of pediatric urinary tract infections in a tertiary care hospital of Nepal. BMC Pediatr. 2019;19(1):36. doi: 10.1186/s12887-019-1410-1
  41. Höller M, Steindl H, Abramov-Sommariva D, et al. Treatment of Urinary Tract Infections with Canephron(®) in Germany: A Retrospective Database Analysis. Antibiotics (Basel). 2021;10(6):685. doi: 10.3390/antibiotics10060685
  42. Brenneis C, Künstle G, Haunschild J. Spasmolytic activity of Canephron N on the contractility of rat and human isolated urinary bladder. In: Proceedings of the 13th Congress of the International Society for Ethnopharmacology. Graz, Austria, 2012.
  43. Sihra N, Goodman A, Zakri R, et al. Nonantibiotic prevention and management of recurrent urinary tract infection. Nat Rev Urol. 2018;15(12):750-76. doi: 10.1038/s41585-018-0106-x
  44. Wagenlehner FM, Abramov-Sommariva D, Höller M, et al. Non-Antibiotic Herbal Therapy (BNO 1045) versus Antibiotic Therapy (Fosfomycin Trometamol) for the Treatment of Acute Lower Uncomplicated Urinary Tract Infections in Women: A Double-Blind, Parallel-Group, Randomized, Multicentre, Non-Inferiority Phase III Trial. Urol Int. 2018;101(3):327-36. doi: 10.1159/000493368
  45. Давидов М.И., Бунова Н.Е. Сравнительная оценка монотерапии препаратами Канефрон Н и ципрофлоксацин острого неосложненного цистита у женщин. Урология. 2018;(4):24-32 [Davidov MI, Bunova NE. Comparative assessment of Canephron N and ciprofloxacin as monotherapy of acute uncomplicated cystitis in women. Urologiia. 2018;(4):24-32 (in Russian)].
  46. Вознесенская Т.С., Кутафина Е.К. Фитотерапия в лечении инфекции мочевой системы у детей. Педиатрическая фармакология. 2007;4(5):38-40 [Voznesenskaia TS, Kutafina EK. Fitoterapiia v lechenii infektsii mochevoi sistemy u detei. Pediatricheskaia farmakologiia. 2007;4(5):38-40 (in Russian)].
  47. Сукало А.В., Крохина С.А., Тур Н.И. Применение препарата Канефрон в комплексной терапии инфекций мочевой системы у детей. Медицинские новости. 2004;11:84-6 [Sukalo AV, Krokhina SA, Tur NI. Preparation Canephron® N use in complex therapy of urinary system infections in children. Medical News. 2004;11:84-6 (in Russian)].
  48. Инфекция мочевых путей у детей. Клинические рекомендации. 2024. Режим доступа: https://cr.minzdrav.gov.ru/view-cr/281_3. Ссылка активна на 08.10.2025 [Infektsiia mochevykh putei u detei. Klinicheskie rekomendatsii. 2024. Available at: https://cr.minzdrav.gov.ru/view-cr/281_3. Accessed: 08.10.2025 (in Russian)].
  49. Abbasian B, Shair A, O’Gorman DB, et al. Potential Role of Extracellular ATP Released by Bacteria in Bladder Infection and Contractility. mSphere. 2019;4(5):e00439-19. doi: 10.1128/mSphere.00439-19
  50. Komesu YM, Richter HE, Carper B, et al. The urinary microbiome in women with mixed urinary incontinence compared to similarly aged controls. Int Urogynecol . 2018;29(12):1785-95. doi: 10.1007/s00192-018-3683-6
  51. Carnes MU, Siddiqui NY, Karstens L, et al. Urinary microbiome community types associated with urinary incontinence severity in women. Am J Obstet Gynecol. 2024;230(3):344.e1-344.e20. doi: 10.1016/j.ajog.2023.10.036
  52. Pearle MS, Goldfarb DS, Assimos DG, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014;192(2):316-24. doi: 10.1016/j.juro.2014.05.006
  53. Zampini A, Nguyen AH, Rose E, et al. Defining Dysbiosis in Patients with Urolithiasis. Sci Rep. 2019;9(1):5425. doi: 10.1038/s41598-019-41977-6
  54. Kachroo N, Monga M, Miller AW. Comparative functional analysis of the urinary tract microbiome for individuals with or without calcium oxalate calculi. Urolithiasis. 2022;50(3):303-17. doi: 10.1007/s00240-022-01314-5
  55. Noonin C, Putpim A, Thongboonkerd V. The direct inhibitory effects of Lactobacillus acidophilus, a commensal urinary bacterium, on calcium oxalate stone development. Microbiome. 2024;12(1):175. doi: 10.1186/s40168-024-01877-y
  56. Liu F, Zhang N, Wu Y, et al. The pelvis urinary microbiome in patients with kidney stones and clinical associations. BMC Microbiol. 2020;20(1):336. doi: 10.1186/s12866-020-01992-4
  57. Barr-Beare E, Saxena V, Hilt EE, et al. The Interaction between Enterobacteriaceae and Calcium Oxalate Deposits. PLoS One. 2015;10(10):e0139575. doi: 10.1371/journal.pone.0139575
  58. Bichler K, Eipper E, Naber K, et al. Urinary infection stones. Int J Antimicrob Agents. 2002;19(6):488-98. doi: 10.1016/s0924-8579(02)00088-2
  59. Shen C, Zhu Q, Dong F, et al. Identifying Two Novel Clusters in Calcium Oxalate Stones With Urinary Tract Infection Using 16S rDNA Sequencing. Front Cell Infect Microbiol. 2021;11:723781. doi: 10.3389/fcimb.2021.723781
  60. EAU Guidelines. Edn. presented at the EAU Annual Congress Madrid 2025. EAU Guidelines Office, Arnhem, the Netherlands. Available at: http://uroweb.org/guidelines/compilations-of-all-guidelines. Accessed: 08.10.2025.
  61. Coco C, Jacobs M. Surgical indications for operative management of vesicoureteral reflux in children. Current Opinion in Pediatrics. 2021;33(2):243-4. doi: 10.1097/mop.0000000000001000

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).